Elucida Oncology (Series A-1)
Funding Details
- Awarder
- Inbox
- Date Award
- January 12, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $44,000,000
Company Info
- Company Description
- Elucida Oncology develops targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer.
- Market
- Cancer Therapy
- Location
- Monmouth Junction, NJ, USA